This is a third-party research done by a grant from YuFoundation for Tom Seyfried to research Dr.Young Ko’s 3 Bromopyruvate antimetabolic drug used in cancers. The important outcome is when 3 BP was injected into the primary cancer site, the metastatic rate was impressively low. Therefore, spread of the cancers may be hindered with this molecule. Please read more in section under grants and scientific information.
Subscribe now to watch over 100 hours of the leading scientists and doctors discussing their research.
Watch video of Nuclear Transfer Studies of Cancer Cells